Nanobiotix S.A. (NBTX) shareholders
Close on Nov 17, 2026Market cap $1.33BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Johnson & Johnson Joint filing with Johnson & Johnson Innovation-JJDC, Inc. (11.90%) | 5,623,816 | 11.90% | 13G (passive) amendment | Dec 31, 2023 |
| Invus Public Equities, L.P. Joint filing with Invus Public Equities Advisors, LLC (9.40%), Invus Global Management, LLC (9.40%) and 2 more | 4,828,374 | 9.40% | 13G (passive) amendment | Jun 30, 2026 |
| Qatar Investment Authority | 3,532,517 | 7.00% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NBTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Johnson & Johnson | 5,623,816 | – | $212.02M | – | 26.55% |
| Morgan Stanley | 49,789 | – | $1.88M | +13,515 | 0.00% |
| Jane Street Group, LLC | 32,180 | – | $1.21M | New | 0.00% |
| Hrt Financial LP | 27,332 | – | $1.03M | New | 0.00% |
| XTX Topco Ltd | 15,855 | – | $597.73K | New | 0.01% |
| Optiver Holding B.V. | 13,631 | – | $513.89K | +130 | 0.00% |
| Marshall Wace, Llp | 10,044 | – | $378.66K | +805 | 0.00% |
| Citadel Advisors LLC | 6,042 | – | $227.78K | New | 0.00% |
| Bnp Paribas Arbitrage, Snc | 4,044 | – | $152.46K | +485 | 0.00% |
| UBS Group AG | 2,577 | – | $97.15K | −2,980 | 0.00% |
| Royal Bank of Canada | 2,189 | – | $83.00K | +364 | 0.00% |
| JPMorgan Chase & Co | 1,706 | – | $61.35K | New | 0.00% |
| Rhumbline Advisers | 1,502 | – | $56.62K | −779 | 0.00% |
| GAMMA Investing LLC | 985 | – | $37.14K | +157 | 0.00% |
| Osaic Holdings, Inc. | 500 | – | $18.85K | – | 0.00% |
| Wells Fargo & Company/Mn | 200 | – | $7.54K | – | 0.00% |
| Stone House Investment Management, LLC | 76 | – | $2.87K | New | 0.00% |
| Federation des caisses Desjardins du Quebec | 56 | – | $2.11K | New | 0.00% |
| National Bank Of Canada /Fi/ | 13 | – | $482 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 19 | 6M | 7 / 6 | 2 / 3 | 0M | 0M |
| Q1 2026 | 15 | 6M | 2 / 3 | 5 / 1 | 0M | 0M |
| Q4 2025 | 14 | 6M | 5 / 5 | 1 / 2 | 0M | 0M |
| Q3 2025 | 11 | 6M | 1 / 0 | 5 / 0 | 0M | 0M |
| Q2 2025 | 10 | 6M | 2 / 3 | 1 / 4 | 0M | 0M |
| Q1 2025 | 12 | 6M | 1 / 2 | 4 / 7 | 0M | 0M |
| Q4 2024 | 18 | 6M | 8 / 3 | 5 / 0 | 0M | 0M |
| Q3 2024 | 10 | 6M | 2 / 1 | 1 / 3 | 0M | 3M |
| Q2 2024 | 12 | 9M | 1 / 3 | 3 / 1 | 0M | 0M |
| Q1 2024 | 12 | 9M | 1 / 4 | 2 / 1 | 0M | 0M |
| Q4 2023 | 12 | 9M | 5 / 2 | 3 / 2 | 6M | 1M |
| Q3 2023 | 9 | 4M | 5 / 1 | 2 / 1 | 2M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
3 funds held NBTX in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NBTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 4,489 | – | $181.36K | 0.00% | May 31, 2026 |
| ActivePassive International Equity ETF | 1,295 | – | $52.32K | 0.01% | May 31, 2026 |
| Steward Values Enhanced International Fund | 1,048 | – | $40.23K | 0.01% | Jul 31, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Nanobiotix's stock actually held short. Settlement fails (shares not delivered on time) peaked at 38,246 shares on Sep 25, 2026 over the last 90 days.
See a number that looks wrong?